首页 | 本学科首页   官方微博 | 高级检索  
     

P2X4受体在瑞芬太尼诱发大鼠术后痛觉过敏中的作用
引用本文:卿文祥,鄢建勤,张成梁,张俊杰,翟振平,呼家佳. P2X4受体在瑞芬太尼诱发大鼠术后痛觉过敏中的作用[J]. 中南大学学报(医学版), 2019, 44(4): 370-376. DOI: 10.11817/j.issn.1672-7347.2019.04.005
作者姓名:卿文祥  鄢建勤  张成梁  张俊杰  翟振平  呼家佳
作者单位:中南大学湘雅三医院麻醉科,长沙,410013;中南大学湘雅医院麻醉科,长沙,410008;中南大学湘雅医院心脏大血管外科,长沙,410008
基金项目:湖南省自然科学基金(2016JJ2156)。
摘    要:目的:探究P2X4受体在阿片类药物诱导的痛觉过敏中的作用。方法:成年雄性Sprague-Dawley(SD)大鼠随机分为尾静脉泵注生理盐水组(N0组)、瑞芬太尼0.5 μg/(kg.min)组(R1组)、瑞芬太尼1.0 μg/(kg.min)组(R2组)、瑞芬太尼1.5 μg/(kg.min)组(R3组)、瑞芬太尼5.0 μg/(kg.min)组(R4组)。于处理前1 d(T1),尾静脉置管后30 min(T2),停药后30 min(T3),1 h(T4),2 h(T5),24 h(T6)测量大鼠机械缩足阈值(paw withdrawal mechanical threshold,PWMT)和热缩足潜伏期(paw withdrawal thermal latency,PWTL),获得诱导痛觉过敏最佳的瑞芬太尼输注速度;随后取成年雄性SD大鼠,分为尾静脉置管后泵入生理盐水组(N组)、尾静脉置管后泵入瑞芬太尼1.0 μg/(kg.min)组(R组)。于上述处理时间点T1,T2,T4测量大鼠PWMT和PWTL,并于停药后1 h选取大鼠脊髓腰膨大检测P2X4受体的mRNA和蛋白表达。另取成年雄性SD大鼠,并将其分为切口痛模型并尾静脉置管后泵入生理盐水组(I+N组)和切口痛模型并尾静脉置管后泵入瑞芬太尼1.0 μg/(kg.min)组(I+R组)。于上述处理时间点T1,T2,T3,T4,T5,T6以及8 h(T7)和72 h(T8)测量大鼠PWMT和PWTL,于停药后1 h取大鼠脊髓腰膨大组织检测P2X4受体的mRNA和蛋白表达,免疫荧光检测小胶质细胞激活的状态。结果:T3和T5时间点PWMT和PWTL的趋势均为R4组0.05)。与I+N组相比,I+R组大鼠在T4,T5,T6时间点的PWMT和PWTL明显降低,差异均有统计学意义(均P<0.05),同时I+R组大鼠脊髓P2X4受体mRNA和蛋白表达水平均明显上调,差异均有统计学意义(均P<0.05)。此外,I+R组大鼠脊髓背角的小胶质细胞的活化较I+N组明显增强。结论:静脉注射瑞芬太尼可致大鼠痛觉过敏,单纯静脉注射瑞芬太尼导致的痛觉过敏可能与P2X4受体无关;瑞芬太尼可导致切口痛大鼠出现更明显的痛觉过敏,其中小胶质细胞活化及P2X4受体可能参与瑞芬太尼诱发术后痛觉过敏的形成机制。

关 键 词:瑞芬太尼  阿片类药物诱发的痛觉过敏  P2X4受体  切口痛

Role of spinal P2X4 receptor in remifentanil-induced postoperative hyperalgesia
QING Wenxiang,YAN Jianqin,ZHANG Chengliang,ZHANG Junjie,ZHAI Zhenping,HU Jiajia. Role of spinal P2X4 receptor in remifentanil-induced postoperative hyperalgesia[J]. Journal of Central South University. Medical sciences, 2019, 44(4): 370-376. DOI: 10.11817/j.issn.1672-7347.2019.04.005
Authors:QING Wenxiang  YAN Jianqin  ZHANG Chengliang  ZHANG Junjie  ZHAI Zhenping  HU Jiajia
Affiliation:1. Department of Anesthesiology, Third Xiangya Hospital, Central South University, Changsha 410013;2. Department of Anesthesiology, Xiangya Hospital, Central South University, Changsha 410008; 3. Department of Cardiovascular Surgery, Xiangya Hospital, Central South University, Changsha 410008, China
Abstract:Objective: To explore the role of P2X4 receptor in opioid-induced hyperalgesia (OIH).Methods: A total of 30 Sprague-Dawley (SD) male rats were randomly divided into 5 groups: asaline (N0) group, a remifentanil at 0.5 μg/(kg.min) (R1) group, a remifentanil at 1.0 μg/(kg.min)(R2) group, a remifentanil at 1.5 μg/(kg.min) (R3) group, and a remifentanil at 5.0 μg/(kg.min)(R4) group. The paw withdrawal mechanical threshold (PWMT) and paw withdrawal thermallatency (PWTL) were measured at follow time points to optimize the dosages: the day beforetreatment (T1), 30 min after tail intravenous catheterization (T2), and 30 min (T3), 1 h (T4), 2h (T5), 24 h (T6) after withdrawal from remifentanil. Then, the rats were randomly divided into 2groups: a saline group (N group), a remifentanil at 1.0 μg/(kg.min) group (R group). The PWMTand PWTL were measured at follow time points: T1, T2, and T4. The lumbar enlargement of spinewas selected at 1 h after withdrawal from remifentanil, and the expression of P2X4 receptor mRNAand protein was examined in OIH. Additional male rats were selected and randomly divided into2 groups: a plantar incision surgery followed by saline treatment group (I+N group), a plantarincision surgery followed by remifentanil treatment group (I+R group). The PWMT and PWTLwere measured at follow time points: T1, T2, T3, T4, T5, T6, 48 h (T7) and 72 h (T8) afterwithdrawal from remifentanil. The lumbar enlargement of spine was selected at 1 h after withdrawalfrom remifentanil, the expression of P2X4 receptor mRNA and protein was examined by PCR andWestern blotting, and the microglial activation in spine 1 h after withdrawal from remifentanil wereassessed by immunofluorescence.Results: The pain thresholds including PWMT and PWTL in different groups were as follows: R4group
Keywords:remifentanil  opioid-induced hyperalgesia  P2X4 receptor  incision pain  
本文献已被 万方数据 等数据库收录!
点击此处可从《中南大学学报(医学版)》浏览原始摘要信息
点击此处可从《中南大学学报(医学版)》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号